世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000040429

乳がんモノクローナル抗体の世界市場(2024-2028)

TechNavio

Global Breast Cancer Monoclonal Antibodies Market 2024-2028

発刊日 2024/07/12

言語英語

体裁PDF/182ページ

ライセンス/価格182ページ

0000040429

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

乳がんモノクローナル抗体市場は、2023年から2028年の間に192億米ドル、予測期間中のCAGRは13.97%で成長すると予測されています。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。乳がんの有病率の増加、乳がん啓発のための患者支援イニシアチブの増加、乳がん治療のための低侵襲治療に対する需要の増加が市場を牽引しています。

調査範囲

  • 市場セグメント
    ➣ エンドユーザー別
      ◇ 病院
      ◇ 調査機関
      ◇ その他
    ➣ タイプ別
      ◇ ヒト化抗体
      ◇ ヒト
      ◇ キメラ抗体
      ◇ ネズミ
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ その他の地域

この調査は、製品承認数の増加と製品パイプラインの拡大が、今後数年間の乳がんモノクローナル抗体市場の成長を促進する主な理由の1つであることを特定しています。また、新興経済国における戦略的提携の数の増加と乳がんの診断と治療への注目の高まりは、市場での相当な需要につながるでしょう。

乳がんモノクローナル抗体市場に関するレポートは、次の分野をカバーしています。

  • 乳がんモノクローナル抗体市場の規模
  • 乳がんモノクローナル抗体市場の予測
  • 乳がんモノクローナル抗体市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

  • 調査企業
    ➣ Amgen Inc.
    ➣ AstraZeneca PLC
    ➣ Boehringer Ingelheim International GmbH
    ➣ Bristol Myers Squibb Co.
    ➣ Celldex Therapeutics Inc.
    ➣ Celltrion Co. Ltd.
    ➣ 第一三共(Daiichi Sankyo Co. Ltd.)
    ➣ エーザイ(Eisai Co. Ltd.)
    ➣ F. Hoffmann La Roche Ltd.
    ➣ Gilead Sciences Inc.
    ➣ Johnson and Johnson Services Inc.
    ➣ MacroGenics Inc.
    ➣ Merck KGaA
    ➣ Novartis AG
    ➣ Pfizer Inc.
    ➣ Puma Biotechnology Inc.
    ➣ Sanofi SA, Seagen Inc.
    ➣ Teva Pharmaceutical Industries Ltd.
    ➣ Viatris Inc.

また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ billion)
Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Breast Cancer Monoclonal Antibodies Market 2018 - 2022
Historic Market Size - Data Table on Global Breast Cancer Monoclonal Antibodies Market 2018 - 2022 ($ billion)
4.2 End-user segment analysis 2018 - 2022
Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
4.3 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ billion)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user
6.1 Market segments
Chart on End-user - Market share 2023-2028 (%)
Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
6.3 Hospitals - Market size and forecast 2023-2028
Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
6.4 Research institutes - Market size and forecast 2023-2028
Chart on Research institutes - Market size and forecast 2023-2028 ($ billion)
Data Table on Research institutes - Market size and forecast 2023-2028 ($ billion)
Chart on Research institutes - Year-over-year growth 2023-2028 (%)
Data Table on Research institutes - Year-over-year growth 2023-2028 (%)
6.5 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ billion)
Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by End-user
Market opportunity by End-user ($ billion)
Data Table on Market opportunity by End-user ($ billion)

7 Market Segmentation by Type
7.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
7.3 Humanized - Market size and forecast 2023-2028
Chart on Humanized - Market size and forecast 2023-2028 ($ billion)
Data Table on Humanized - Market size and forecast 2023-2028 ($ billion)
Chart on Humanized - Year-over-year growth 2023-2028 (%)
Data Table on Humanized - Year-over-year growth 2023-2028 (%)
7.4 Human - Market size and forecast 2023-2028
Chart on Human - Market size and forecast 2023-2028 ($ billion)
Data Table on Human - Market size and forecast 2023-2028 ($ billion)
Chart on Human - Year-over-year growth 2023-2028 (%)
Data Table on Human - Year-over-year growth 2023-2028 (%)
7.5 Chimeric - Market size and forecast 2023-2028
Chart on Chimeric - Market size and forecast 2023-2028 ($ billion)
Data Table on Chimeric - Market size and forecast 2023-2028 ($ billion)
Chart on Chimeric - Year-over-year growth 2023-2028 (%)
Data Table on Chimeric - Year-over-year growth 2023-2028 (%)
7.6 Murine - Market size and forecast 2023-2028
Chart on Murine - Market size and forecast 2023-2028 ($ billion)
Data Table on Murine - Market size and forecast 2023-2028 ($ billion)
Chart on Murine - Year-over-year growth 2023-2028 (%)
Data Table on Murine - Year-over-year growth 2023-2028 (%)
7.7 Market opportunity by Type
Market opportunity by Type ($ billion)
Data Table on Market opportunity by Type ($ billion)

8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ billion)
Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ billion)
Data Table on US - Market size and forecast 2023-2028 ($ billion)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 France - Market size and forecast 2023-2028
Chart on France - Market size and forecast 2023-2028 ($ billion)
Data Table on France - Market size and forecast 2023-2028 ($ billion)
Chart on France - Year-over-year growth 2023-2028 (%)
Data Table on France - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ billion)
Data Table on China - Market size and forecast 2023-2028 ($ billion)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 The Netherlands - Market size and forecast 2023-2028
Chart on The Netherlands - Market size and forecast 2023-2028 ($ billion)
Data Table on The Netherlands - Market size and forecast 2023-2028 ($ billion)
Chart on The Netherlands - Year-over-year growth 2023-2028 (%)
Data Table on The Netherlands - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ billion)
Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
12.4 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
12.5 Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH - Overview
Boehringer Ingelheim International GmbH - Product / Service
Boehringer Ingelheim International GmbH - Key news
Boehringer Ingelheim International GmbH - Key offerings
12.6 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
12.7 Celldex Therapeutics Inc
Celldex Therapeutics Inc - Overview
Celldex Therapeutics Inc - Product / Service
Celldex Therapeutics Inc - Key offerings
12.8 Daiichi Sankyo Co. Ltd.
Daiichi Sankyo Co. Ltd. - Overview
Daiichi Sankyo Co. Ltd. - Product / Service
Daiichi Sankyo Co. Ltd. - Key news
Daiichi Sankyo Co. Ltd. - Key offerings
12.9 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.10 Gilead Sciences Inc.
Gilead Sciences Inc. - Overview
Gilead Sciences Inc. - Product / Service
Gilead Sciences Inc. - Key news
Gilead Sciences Inc. - Key offerings
12.11 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
12.12 MacroGenics Inc.
MacroGenics Inc. - Overview
MacroGenics Inc. - Product / Service
MacroGenics Inc. - Key offerings
12.13 Merck KGaA
Merck KGaA - Overview
Merck KGaA - Business segments
Merck KGaA - Key news
Merck KGaA - Key offerings
Merck KGaA - Segment focus
12.14 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.15 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.16 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
12.17 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Breast Cancer Monoclonal Antibodies Market 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on End-user - Market share 2023-2028 (%)
Exhibits33: Data Table on End-user - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by End-user
Exhibits35: Data Table on Comparison by End-user
Exhibits36: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibits37: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibits38: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Research institutes - Market size and forecast 2023-2028 ($ billion)
Exhibits41: Data Table on Research institutes - Market size and forecast 2023-2028 ($ billion)
Exhibits42: Chart on Research institutes - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Research institutes - Year-over-year growth 2023-2028 (%)
Exhibits44: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits45: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits46: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits47: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits48: Market opportunity by End-user ($ billion)
Exhibits49: Data Table on Market opportunity by End-user ($ billion)
Exhibits50: Chart on Type - Market share 2023-2028 (%)
Exhibits51: Data Table on Type - Market share 2023-2028 (%)
Exhibits52: Chart on Comparison by Type
Exhibits53: Data Table on Comparison by Type
Exhibits54: Chart on Humanized - Market size and forecast 2023-2028 ($ billion)
Exhibits55: Data Table on Humanized - Market size and forecast 2023-2028 ($ billion)
Exhibits56: Chart on Humanized - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Humanized - Year-over-year growth 2023-2028 (%)
Exhibits58: Chart on Human - Market size and forecast 2023-2028 ($ billion)
Exhibits59: Data Table on Human - Market size and forecast 2023-2028 ($ billion)
Exhibits60: Chart on Human - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on Human - Year-over-year growth 2023-2028 (%)
Exhibits62: Chart on Chimeric - Market size and forecast 2023-2028 ($ billion)
Exhibits63: Data Table on Chimeric - Market size and forecast 2023-2028 ($ billion)
Exhibits64: Chart on Chimeric - Year-over-year growth 2023-2028 (%)
Exhibits65: Data Table on Chimeric - Year-over-year growth 2023-2028 (%)
Exhibits66: Chart on Murine - Market size and forecast 2023-2028 ($ billion)
Exhibits67: Data Table on Murine - Market size and forecast 2023-2028 ($ billion)
Exhibits68: Chart on Murine - Year-over-year growth 2023-2028 (%)
Exhibits69: Data Table on Murine - Year-over-year growth 2023-2028 (%)
Exhibits70: Market opportunity by Type ($ billion)
Exhibits71: Data Table on Market opportunity by Type ($ billion)
Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits73: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits74: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits75: Chart on Geographic comparison
Exhibits76: Data Table on Geographic comparison
Exhibits77: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits78: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits79: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits82: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits83: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits86: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits87: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits94: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits95: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibits98: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibits99: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits102: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits103: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits105: Chart on The Netherlands - Market size and forecast 2023-2028 ($ billion)
Exhibits106: Data Table on The Netherlands - Market size and forecast 2023-2028 ($ billion)
Exhibits107: Chart on The Netherlands - Year-over-year growth 2023-2028 (%)
Exhibits108: Data Table on The Netherlands - Year-over-year growth 2023-2028 (%)
Exhibits109: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits110: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits111: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits112: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits113: Market opportunity By Geographical Landscape ($ billion)
Exhibits114: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits115: Impact of drivers and challenges in 2023 and 2028
Exhibits116: Overview on criticality of inputs and factors of differentiation
Exhibits117: Overview on factors of disruption
Exhibits118: Impact of key risks on business
Exhibits119: Companies covered
Exhibits120: Matrix on companies position and classification
Exhibits121: Amgen Inc. - Overview
Exhibits122: Amgen Inc. - Product / Service
Exhibits123: Amgen Inc. - Key news
Exhibits124: Amgen Inc. - Key offerings
Exhibits125: AstraZeneca Plc - Overview
Exhibits126: AstraZeneca Plc - Product / Service
Exhibits127: AstraZeneca Plc - Key news
Exhibits128: AstraZeneca Plc - Key offerings
Exhibits129: Boehringer Ingelheim International GmbH - Overview
Exhibits130: Boehringer Ingelheim International GmbH - Product / Service
Exhibits131: Boehringer Ingelheim International GmbH - Key news
Exhibits132: Boehringer Ingelheim International GmbH - Key offerings
Exhibits133: Bristol Myers Squibb Co. - Overview
Exhibits134: Bristol Myers Squibb Co. - Product / Service
Exhibits135: Bristol Myers Squibb Co. - Key news
Exhibits136: Bristol Myers Squibb Co. - Key offerings
Exhibits137: Celldex Therapeutics Inc - Overview
Exhibits138: Celldex Therapeutics Inc - Product / Service
Exhibits139: Celldex Therapeutics Inc - Key offerings
Exhibits140: Daiichi Sankyo Co. Ltd. - Overview
Exhibits141: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits142: Daiichi Sankyo Co. Ltd. - Key news
Exhibits143: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits144: F. Hoffmann La Roche Ltd. - Overview
Exhibits145: F. Hoffmann La Roche Ltd. - Business segments
Exhibits146: F. Hoffmann La Roche Ltd. - Key news
Exhibits147: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits148: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits149: Gilead Sciences Inc. - Overview
Exhibits150: Gilead Sciences Inc. - Product / Service
Exhibits151: Gilead Sciences Inc. - Key news
Exhibits152: Gilead Sciences Inc. - Key offerings
Exhibits153: Johnson and Johnson Services Inc. - Overview
Exhibits154: Johnson and Johnson Services Inc. - Business segments
Exhibits155: Johnson and Johnson Services Inc. - Key news
Exhibits156: Johnson and Johnson Services Inc. - Key offerings
Exhibits157: Johnson and Johnson Services Inc. - Segment focus
Exhibits158: MacroGenics Inc. - Overview
Exhibits159: MacroGenics Inc. - Product / Service
Exhibits160: MacroGenics Inc. - Key offerings
Exhibits161: Merck KGaA - Overview
Exhibits162: Merck KGaA - Business segments
Exhibits163: Merck KGaA - Key news
Exhibits164: Merck KGaA - Key offerings
Exhibits165: Merck KGaA - Segment focus
Exhibits166: Novartis AG - Overview
Exhibits167: Novartis AG - Business segments
Exhibits168: Novartis AG - Key news
Exhibits169: Novartis AG - Key offerings
Exhibits170: Novartis AG - Segment focus
Exhibits171: Pfizer Inc. - Overview
Exhibits172: Pfizer Inc. - Product / Service
Exhibits173: Pfizer Inc. - Key news
Exhibits174: Pfizer Inc. - Key offerings
Exhibits175: Sanofi SA - Overview
Exhibits176: Sanofi SA - Business segments
Exhibits177: Sanofi SA - Key news
Exhibits178: Sanofi SA - Key offerings
Exhibits179: Sanofi SA - Segment focus
Exhibits180: Viatris Inc. - Overview
Exhibits181: Viatris Inc. - Business segments
Exhibits182: Viatris Inc. - Key news
Exhibits183: Viatris Inc. - Key offerings
Exhibits184: Viatris Inc. - Segment focus
Exhibits185: Inclusions checklist
Exhibits186: Exclusions checklist
Exhibits187: Currency conversion rates for US$
Exhibits188: Research methodology
Exhibits189: Information sources
Exhibits190: Data validation
Exhibits191: Validation techniques employed for market sizing
Exhibits192: Data synthesis
Exhibits193: 360 degree market analysis
Exhibits194: List of abbreviations

この商品のレポートナンバー

0000040429

TOP